Back

Subgroup analysis of patients with concomitant pulmonary embolism in XALIA, a non-interventional study of rivaroxaban in routine treatment of deep vein thrombosis

29 August 2016 (15:35 - 15:42)
Organised by:
Congress Presentation Part of: Advances in pulmonary embolism Acute pulmonary embolism ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Walter Ageno

University of Padua, Padova (Italy)

6 More presentations in this session

Presentation thumbnail
Prothrombotic fibrin clot phenotype is associated with recurrent pulmonary embolism following discontinuation of anticoagulant therapy
Professor A. Undas (Krakow, PL)
Abstract Slides
Presentation thumbnail
Home treatment of patients with pulmonary embolism: the experience of a referral centre in Italy
Doctor G. Cerini (Florence, IT)
Abstract
Presentation thumbnail
E-selectin and sICAM-1, biomarker of endothelial function, predicts venous thromboembolism recurrence in young patients.
Doctor M. Kostrubiec (Cork, IE)
Abstract Slides
Presentation thumbnail
Costs of major adverse outcomes in patients with incident venous thromboembolism in clinical practice in the United Kingdom
Doctor A. Cohen (London, GB)
Abstract Slides
Presentation thumbnail
Echocardiography in the post-acute, pre-discharge assessment of pulmonary embolism: prevalence and prognostic impact of right ventricular dysfunction and residual pulmonary hypertension
Assistant Professor B. Jug (Ljubljana, SI)
Abstract Slides

Access the full session

Session thumbnail
Advances in pulmonary embolism

The Event

Event poster

ESC Congress 2016

29 August 2016 15:35 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources